Cetirizine release from cyclodextrin formulated compressed chewing gum

Drug Development and Industrial Pharmacy

Volumn 38, Issue 9, 2012, Pages 1061-1067

  Stojanov, Mladen ^a   Larsen, Kim L ^a  

^a AALBORG UNIVERSITY   (Denmark)

Author keywords

Cetirizine; Chewing gum; Complex; Cyclodextrin; Drug release

Indexed keywords

CETIRIZINE; CYCLODEXTRIN;

ARTICLE; CHEWING GUM; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASTICATION;

ALPHA-CYCLODEXTRINS; ANALYSIS OF VARIANCE; ANTI-ALLERGIC AGENTS; BETA-CYCLODEXTRINS; CETIRIZINE; CHEMISTRY, PHARMACEUTICAL; CHEWING GUM; CYCLODEXTRINS; EXCIPIENTS; GAMMA-CYCLODEXTRINS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; KINETICS; MECHANICAL PHENOMENA; PHARMACEUTICAL VEHICLES; PHYSICOCHEMICAL PHENOMENA; PRESSURE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84864470939     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.638301     Document Type: Article

References (27)

1. Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci, 85:1017-1025.
2. Szejtli J, Szente L. (2005). Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm, 61:115-125.
3. Uekama K, Hirayama F, Irie T. (1998). Cyclodextrin Drug Carrier Systems. Chem Rev, 98:2045-2076.
4. Brewster ME, Loftsson T. (2007). Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev, 59:645-666.
5. Del Valle MEM. (2003). Cyclodextrins and their uses: A review. Process Biochem, 39:1033-1046.
6. Hedges AR. (1998). Industrial Applications of Cyclodextrins. Chem Rev, 98:2035-2044.
7. Valentino JS, Rajewski AR. (1997). Cyclodextrins: Their future in drug formulation and delivery. Pharm Res Dordr, 14:556-567.
8. Rassing RM. (1994). Chewing gum as a drug delivery system. Adv Drug Deliver Rev, 13:89-121.
9. Hirayama F, Uekama K. (1999). Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev, 36:125-141.
10. Stojanov M, Wimmer R, Larsen KL. (2011). Study of the inclusion complexes formed between cetirizine and a-, b-, and g-cyclodextrin and evaluation on their taste-masking properties. J Pharm Sci, 100:3177-3185.
11. Cramer F, Saenger W, Spatz H.-Ch. (1967). Inclusion compounds. XIX. The formation of inclusion compounds of a-cyclodextrin in aqueous solutions. Thermodynamics and kinetics. J Am Chem Soc, 89:14-20.
12. Skidgel RA, Erdos EG. (2005). Hystamine, bradykinin and their antagonists. In: Brunton LL et al. ed Goodman and Gilman's The Pharmacological Basis of Therapeutics - 11th ed. New York: The McGraw-Hill companies, 629-651.
13. Andersen C, Lao ML. (2010). Stable medicated chewing gum comprising cyclodextrin inclusion complex. Fertin Pharma AS. EP2178521 (A1).
14. Jacobsen J, Bjerregaard S, Pedersen M. (1999). Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity-drug supersaturation, toxicity on TR146 cells and release from a delivery system. Eur J Pharm Biopharm, 48:217-224.
15. Testa ES. (1996). Medicated chewing gum and a process for preparation thereof. Avant-Garde Technologies & Products S.A. US005866179A .
16. Yoshii H. (2007). Release kinetics of (-)-menthol from chewing gum. J Incl Phenom Macro, 57:591-596.
17. Andersen RB, Nissen V. (2008). Compressed chewing gum tablet. Gumlink AS. EP1967234 (A1).
18. Kvist C, Andersson SB, Fors S, Wennergren B, Berglund J. (1999). Apparatus for studying in vitro drug release from medicated chewing gums. Int J Pharm, 189:57-65.
19. Morjaria Y, Irwin WJ, Barnett PX, Chan RS, Conway BR. (2004). In vitro release of nicotine from chewing gum formulations. Dissol Technol, 12-15.
20. European Directorate for the Quality of Medicines & HealthCare. (2011). The European Pharmacopoeia. 7th Ed. Strasbourg: Council of Europe.
21. Mikkelsen R. (2004). Method for producing compressed chewing gum tablets. WO2004/098305.
22. Andersen C, Thorengaard B. (2010). Chewing gum granules for compressed chewing gum. Gumlink AS. EP2162016 (A1).
23. Christensen PHE, Mikkelsen R. (2009). Compressed chewing gum tablets comprising at least gum granules. Gumlink AS. EP2022336 (A1).
24. Cavallari C, Albertini B, González-Rodríguez ML, Rodriguez L, Abertini B. (2002). Improved dissolution behaviour of steamgranulated piroxicam. Eur J Pharm Biopharm, 54:65-73.
25. Rawata S, Jain KS. (2004). Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes. Eur J Pharm Biopharm, 57:263-267.
26. Riekes MK, Monika Piazzon Tagliari, Andrea Granada, Gislaine Kuminek, Marcos Antonio Segatto Silva, Hellen Karine Stulzer, et al. (2010). Enhanced solubility and dissolution rate of amiodarone by complexation with β-cyclodextrin through different methods. Materials Science and Engineering C, 30, 1008-1013.
27. Pagliara A, Testa B, Carrupt PA, Jolliet P, Morin C, Morin D et al. (1998). Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist. J Med Chem, 41:853-863.